BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34601694)

  • 1. Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan.
    Hayakawa A; Sato I; Kamibeppu K; Ishida Y; Inoue M; Sato A; Shiohara M; Yabe H; Koike K; Adachi S; Atsuta Y; Yamashita T; Kanda Y; Okamoto S
    Int J Hematol; 2022 Jan; 115(1):123-128. PubMed ID: 34601694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
    Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood.
    Ishida Y; Kamibeppu K; Sato A; Inoue M; Hayakawa A; Shiobara M; Yabe H; Koike K; Adachi S; Yamashita T; Kanda Y; Okamoto S; Atsuta Y
    Int J Hematol; 2022 Nov; 116(5):787-797. PubMed ID: 36056987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation.
    Diep PP; Rueegg CS; Burman MM; Brinch L; Bø K; Fosså K; Landrø L; Loge JH; Lund MB; Massey RJ; Myrdal OH; Pathak M; Rimstad L; Tanem KE; Tjønnfjord GE; Aaløkken TM; Ruud E
    J Adolesc Young Adult Oncol; 2023 Feb; 12(1):66-75. PubMed ID: 35544321
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.
    Soejima T; Shiohara M; Ishida Y; Inoue M; Hayakawa A; Sato A; Kamibeppu K; Atsuta Y; Yamashita T
    Int J Hematol; 2021 Apr; 113(4):566-575. PubMed ID: 33386599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.
    Kurosawa S; Yamaguchi T; Oshima K; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1851-1858. PubMed ID: 31129353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey.
    McErlean G; Tapp C; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I
    BMC Psychol; 2023 Aug; 11(1):235. PubMed ID: 37587508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation.
    Cheon J; Lee YJ; Jo JC; Kweon K; Koh S; Min YJ; Park SH; Lee SH; Kim HJ; Choi Y
    Support Care Cancer; 2021 Feb; 29(2):975-986. PubMed ID: 32556712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported symptom burden and impact on daily activities in chronic graft-versus-host disease.
    Yu J; Hamilton BK; Turnbull J; Stewart SK; Vernaya A; Bhatt V; Meyers O; Galvin J
    Cancer Med; 2023 Feb; 12(3):3623-3633. PubMed ID: 36394207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients.
    Uygun V; Tayfun F; Akcan M; Karasu GT; Kupesiz A; Hazar V; Yeşilipek A
    Pediatr Hematol Oncol; 2012 Aug; 29(5):461-71. PubMed ID: 22712884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
    Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Recipient Health-Related Quality of Life and Donor-Recipient Relationship following Sibling Pediatric Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Pieczonka A; Barańska M; Wachowiak J
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):401-406. PubMed ID: 31622770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
    Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
    Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD.
    Rovó A; Tichelli A; Passweg JR; Heim D; Meyer-Monard S; Holzgreve W; Gratwohl A; De Geyter C
    Blood; 2006 Aug; 108(3):1100-5. PubMed ID: 16543466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia.
    Dyer G; Gilroy N; Brice L; Kabir M; Gottlieb D; Huang G; Hogg M; Brown L; Greenwood M; Larsen SR; Moore J; Hertzberg M; Tan J; Ward C; Kerridge I
    Transpl Infect Dis; 2019 Apr; 21(2):e13043. PubMed ID: 30585673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and recovery after graft-versus-host disease.
    Baker KS; Fraser CJ
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):333-41. PubMed ID: 18503996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.
    DePalo J; Chai X; Lee SJ; Cutler CS; Treister N
    Oral Oncol; 2015 Oct; 51(10):944-9. PubMed ID: 26277616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in 244 recipients of allogeneic bone marrow transplantation.
    Chiodi S; Spinelli S; Ravera G; Petti AR; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Frassoni F; Bacigalupo A
    Br J Haematol; 2000 Sep; 110(3):614-9. PubMed ID: 10997973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do we need to know about allogeneic hematopoietic stem cell transplant survivors?
    Clark CA; Savani M; Mohty M; Savani BN
    Bone Marrow Transplant; 2016 Aug; 51(8):1025-31. PubMed ID: 27064688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantation.
    Harris BA; Berger AM; Mitchell SA; Steinberg SM; Baker KL; Handel DL; Bolle JL; Bush EG; Avila D; Pavletic SZ
    J Support Oncol; 2010; 8(3):119-25. PubMed ID: 20552925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.